13 Analysts Have This To Say About Elevance Health
13 Analysts Have This To Say About Elevance Health
13位分析師對Elevance Health發表瞭如下評論:
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $600.08, along with a high estimate of $643.00 and a low estimate of $530.00. A negative shift in sentiment is evident as analysts have decreased the average price target by...13 analysts have expressed a variety of opinions on Elevance Health (NYSE:ELV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度裏，有13位分析師對Elevance Health (紐交所:ELV) 發表了各種不同的觀點，從看好到看淡，觀點紛呈。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $600.08, along with a high estimate of $643.00 and a low estimate of $530.00. A negative shift in sentiment is evident as analysts have decreased the average price target by...
Providing deeper insights, analysts have ...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間